T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation Johannes ScheteligAlexander KianiMartin Bornhäuser Review 11 May 2005 Pages: 1043 - 1058
CD3 × CD28 cross-interacting bispecific antibodies improve tumor cell dependent T-cell activation An WillemsSteve SchoonoogheNico Mertens Original Article 13 May 2005 Pages: 1059 - 1071
Immune responses to p53 in patients with cancer:enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites Andreas E. AlbersRobert L. FerrisTheresa L. Whiteside Original Article 16 June 2005 Pages: 1072 - 1081
Induction of Th1-type immunity and tumor protection with a prostate-specific antigen DNA vaccine Deborah J. MarshallLani R. San MateoLinda A. Snyder Original Article 27 July 2005 Pages: 1082 - 1094
Low-dose IL-2 induces cytokine cascade, eosinophilia, and a transient Th2 shift in melanoma patients William Chad CragunGalina V. YamshchikovCraig L. Slingluff Jr Original Article 12 May 2005 Pages: 1095 - 1105
Induction of anti B-cell malignance CTL response by subfamily-shared peptides derived from variable domain of immunoglobulin heavy chain Guo XiaolingLiu YingZhu Ping Original Article 12 May 2005 Pages: 1106 - 1114
Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages Hui LiMing Y. CaoAiping H. Young Original Article 13 May 2005 Pages: 1115 - 1126
Tumor counterattack: fact or fiction? Frederik H. IgneyPeter H. Krammer Symposium Paper 12 May 2005 Pages: 1127 - 1136
Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression Pratima SinhaVirginia K. ClementsSuzanne Ostrand-Rosenberg Symposium Paper 05 May 2005 Pages: 1137 - 1142
The interplay between innate and adaptive immunity regulates cancer development K. E. de VisserL. M. Coussens Symposium Paper 12 May 2005 Pages: 1143 - 1152
